Shan Yu

3.5k citations
89 papers · 2.4k indexed · h-index 32
Topics
Prostate Cancer Treatment and Research (17 papers)Estrogen and related hormone effects (14 papers)MicroRNA in disease regulation (11 papers)

In The Last Decade

Shan Yu

88 papers receiving 2.4k citations

Peers

Shan Yu
Comparison fields: 5 of 112
  • Molecular Biology 1.5k
  • Cancer Research 749
  • Genetics 415
  • Oncology 401
  • Pulmonary and Respiratory Medicine 350
Replace Nicola Perrotti with:
Nicola Perrotti Italy
Qiong Shi China
Ju-Jun Xie China
Hiromichi Fujino Japan
Pascal Bernatchez Canada
Ingeborg Hers United Kingdom
Larissa Lipskaia France
Nicolas Tajeddine Belgium
Naseema M. Hoosein United States
Mohd W. Nasser United States
Shan Yu relative to Nicola Perrotti Italy Nicola Perrotti's profile →
Citations per field
00.5×
Nicola Perrotti · 1×
Citations per year

Countries citing papers authored by Shan Yu

Since Specialization
Citations

This map shows the geographic impact of Shan Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shan Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shan Yu more than expected).

Fields of papers citing papers by Shan Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shan Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shan Yu. The network helps show where Shan Yu may publish in the future.

Co-authorship network of co-authors of Shan Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Shan Yu. A scholar is included among the top collaborators of Shan Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shan Yu. Shan Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 4
3 2
4 10
5 6
6 2
7 7
8 37
9 13
10 23
11 38
12 44
13 45
14 60
15 150
16 20
17 6
18 20
19
Effect of Xiaotan Sanjie Decoction on the expression of IL-6 in mice with gastric tansplanted tumor and gastric tissues beside tumor
2
20 9

About Shan Yu

Shan Yu is a scholar working on Cancer Research, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 89 papers that have together received 2.4k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (17 papers), Estrogen and related hormone effects (14 papers) and MicroRNA in disease regulation (11 papers). The work is most often cited by research in Cancer Research (749 citations), Sensory Systems (155 citations) and Molecular Biology (1.5k citations). Shan Yu has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Franky Leung Chan, Chi‐Fai Ng, Dinglan Wu, Xiaoqiang Yao, Yü Huang, Chang Zou, Yuliang Wang, Mian Guo, Shiuan Chen and Xianghong Wang. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Communications and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026